Loading Events

Manufacturing of Nanomedicines by microfluidics

• Oct 20th at 13:00 | Speakers: Paul Stainton, Eman Jaradat | Chair: Kofi Asare-Addo

VIRTUAL MEETING – 20th October 2022


The APS Emerging Technologies Focus Group, is pleased to announce their webinar which will offer plenty of opportunities for discussions. This meeting will bring together expert speakers from academia and industry and will include a talk from a junior researcher and a talk from a senior researcher from industry or academia.

Who should attend

This meeting is ideally suited for PhD Candidates, Academics, Industrialists, Specialist Technology Providers, and Regulatory Personnel. Overall, the content of this special series has been carefully crafted to complement the existing APS portfolio and the Emerging Technologies Focus Group hot topics.


20 October 2022 – 13.00-14.00 GMT
Manufacturing of Nanomedicines by microfluidics


APS Members- Free
(Please get your code from the members hub for FREE tickets)

APS Student Members- Free
(Please get your code from the members hub for FREE tickets)

APS Non-Members- £15*

APS Student Non-Members- £10*

* All ticket prices exclude VAT

Paul Stainton – Principal Scientist – Pharmaceutical Sciences at Genevant Sciences Corp.

Paul completed his Master’s in Chemistry with industrial experience at the University of Bradford in 2013. He worked for two years as an analytical scientist for Reckitt Benckiser and GSK. He then went to do a PhD in pharmaceutical sciences in 2018 from the University of Lincoln. His project was in the nucleation and growth of crystalline nanoparticles, using microfluidics to crystallize hard-to-crystallize material. He then moved to work in lipid nanoparticles for RNA delivery at Genevant Sciences Corp. in Vancouver Canada where he worked to understand LNP formation and encapsulation, develop new ways of making LNP, and improve the stability of mRNA-loaded LNPs.

Eman Jaradat – PhD Researcher, Queen’s University Belfast

Eman Jaradat joined Queens University Belfast as a Ph.D. researcher in 2021. Her research is about microfluidics technology and its capacity to produce different types of nanoparticles (NP). Eman works on encapsulating chemotherapy within Lipid-based NP  (LNP) to target drug delivery as a drug delivery system (DDSs).